Seeing Diabetes Through Heart-Shaped Glasses: Multidisciplinary Perspectives on the Management of Comorbid Type 2 Diabetes and Cardiovascular Disease

Date: Monday, Nov. 14
Time: 7-9:15 p.m.
Sponsored by: The Institute for Medical and Nursing Education, Inc.
Supported by: Boehringer Ingelheim, Inc., and Lilly USA, LLC
Location: Hilton New Orleans Riverside, Grand Salon A & B
Address: Two Poydras St.
Register for this event at:

Cardiologists play a collaborative role in the management of patients with type 2 diabetes mellitus (T2DM) and, therefore, should be knowledgeable about the interrelated risks of diabetes, glycemic control, and cardiovascular disease (CVD). Cardiovascular (CV) drugs can alter glycemic variables, and antihyperglycemic agents may alter CV parameters. As experts on CVD, cardiologists and related healthcare providers should be aware of the clinically important differences in CV outcomes reported for the major classes of agents used to treat CVD and T2DM. This timely symposium will review the effects of antihyperglycemic agents used in the management of T2DM on CV risk factors and outcomes. This interactive symposium will alternate between didactic presentations and case-based discussion segments. The presentations will examine specific effects of various antihyperglycemic agents on CV risk factors and outcomes, while the case presentations will differ in clinical complexity and will be discussed from multiple perspectives: cardiologist, endocrinologist, and primary care physician. Participants will be able to submit questions to the expert faculty throughout the symposium.


This e-mail is being sent as information only and does not reflect the opinions of the AHA, nor does AHA review or approve the programming. These events are not part of the official scientific sessions as planned by the AHA committee on Scientific Sessions programming. These events are part of the unofficial symposia offered concurrently with Scientific Sessions 2016.